YCBD (cbdMD, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
cbdMD, Inc. Common Stock (YCBD) is a publicly traded Healthcare sector company. As of May 21, 2026, YCBD trades at $0.74 with a market cap of $8.08M and a P/E ratio of 5.17. YCBD moved -2.64% today. Year to date, YCBD is -33.21%; over the trailing twelve months it is -20.00%. Its 52-week range spans $0.47 to $6.54. Analyst consensus is buy with an average price target of $2.00. Rallies surfaces YCBD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns YCBD stock?
Hedge funds tracked by Rallies that own YCBD include Two Sigma and Renaissance Technologies. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for cbdMD, Inc. Common Stock.
YCBD Key Metrics
Key financial metrics for YCBD
Metric
Value
Price
$0.74
Market Cap
$8.08M
P/E Ratio
5.17
EPS
$0.14
Dividend Yield
0.00%
52-Week High
$6.54
52-Week Low
$0.47
Volume
1.12K
Avg Volume
0
Revenue (TTM)
$19.98M
Net Income
$-2.66M
Gross Margin
59.38%
Top Hedge Funds Holding YCBD
Two Sigma holds 16.11K shares of YCBD, changed -26.98% as of Dec 31, 2024.
Renaissance Technologies holds 12.61K shares of YCBD, changed -64.97% as of Jun 30, 2024.
Hedge funds tracked by Rallies that own YCBD include Two Sigma and Renaissance Technologies. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for cbdMD, Inc. Common Stock.
Does Rallies show 13F holders for YCBD?
Yes. Rallies tracks hedge fund and 13F ownership data for YCBD, including fund names, share counts, latest tracked quarter, and position changes when available.
Is YCBD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for YCBD. It does not provide personalized investment advice.
